These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species. Leitão JH; Sousa SA; Ferreira AS; Ramos CG; Silva IN; Moreira LM Appl Microbiol Biotechnol; 2010 Jun; 87(1):31-40. PubMed ID: 20390415 [TBL] [Abstract][Full Text] [Related]
17. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection. Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078 [TBL] [Abstract][Full Text] [Related]
18. Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex. Seed KD; Dennis JJ Antimicrob Agents Chemother; 2009 May; 53(5):2205-8. PubMed ID: 19223640 [TBL] [Abstract][Full Text] [Related]
19. Resistance of the Burkholderia cepacia complex to fosmidomycin and fosmidomycin derivatives. Messiaen AS; Verbrugghen T; Declerck C; Ortmann R; Schlitzer M; Nelis H; Van Calenbergh S; Coenye T Int J Antimicrob Agents; 2011 Sep; 38(3):261-4. PubMed ID: 21724375 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of essential oils against multidrug-resistant clinical isolates of the Burkholderia cepacia complex. Vasireddy L; Bingle LEH; Davies MS PLoS One; 2018; 13(8):e0201835. PubMed ID: 30071118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]